Radioimmunotherapy study advances new lymphoma treatment

07/11/2013 | (free registration)

A study published in the Journal of Nuclear Medicine demonstrates the safety and efficacy of radioimmunotherapy using lutetium-177 DOTA rituximab in patients with certain B-cell lymphomas, according to researchers. The clinical trial also revealed that the new treatment option requires less radiation and delivers favorable tumor response.

View Full Article in: (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
In house Compliance Officer
Pompano Beach, FL